ALDX
ALDX
US01438T1060
Aldeyra Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
55.28M EUR
128.48M EUR
101.94M EUR
311.64M EUR
Enterprise Value
12.23M EUR
83.54M EUR
52.45M EUR
257.13M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.33x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.46x
3.39x
2.42x
7.04x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.51x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-28.25%
-17.16%
-25.49%
-6.7%
ende